[Federal Register Volume 85, Number 113 (Thursday, June 11, 2020)]
[Notices]
[Page 35664]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-12625]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-663]


Importer of Controlled Substances Application: Cardinal Health

ACTION: Notice of application.

-----------------------------------------------------------------------

DATES: Registered bulk manufacturers of the affected basic class(es), 
and applicants therefore, may file written comments on or objections to 
the issuance of the proposed registration on or before July 13, 2020. 
Such persons may also file a written request for a hearing on the 
application on or before July 13, 2020.

ADDRESSES: Written comments should be sent to: Drug Enforcement 
Administration, Attention: DEA Federal Register Representative/DPW, 
8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a 
hearing must be sent to: Drug Enforcement Administration, Attn: 
Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All 
requests for a hearing should also be sent to: (1) Drug Enforcement 
Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, 
Springfield, Virginia 22152; and (2) Drug Enforcement Administration, 
Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, 
Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this 
is notice that on June 1, 2020, Cardinal Health, 15 Ingram Boulevard, 
La Vergne, Tennessee 37086-3630, applied to be registered as an 
importer of the following basic class(es) of controlled substance:

------------------------------------------------------------------------
                                           Drug
          Controlled substance             code          Schedule
------------------------------------------------------------------------
Secobarbitol...........................     2315  II
------------------------------------------------------------------------

    The company plans to import the above controlled substance in 
finished dosage form for distribution to licensed registrants for the 
purpose of medical use only.

William T. McDermott,
Assistant Administrator.
[FR Doc. 2020-12625 Filed 6-10-20; 8:45 am]
BILLING CODE 4410-09-P